Virginia Ferraresi

5PUBLICATIONS
97CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Jul 30, 2026
Feasibility and activity of concurrent neoadjuvant chemotherapy and radiation therapy in patients with high-risk soft tissue sarcoma.

|Jul 25, 2025
Tumor Immune Microenvironment-Associated Prognostic and Mifamurtide-Response Gene Signatures for Localized Osteosarcoma: A Correlative Study of the ISG/OS-2 Trial.

Emanuela Palmerini, Maria Rosaria Sapienza, Stefano A Pileri

|Jan 20, 2025
Intensified Induction Therapy for Newly Diagnosed, Localized Skeletal Ewing Sarcoma (ISG/AIEOP EW-1): A Randomized, Open-Label, Phase 3, Non-Inferiority Trial.

Roberto Luksch, Emanuela Palmerini, Giuseppe Maria Milano

|Nov 10, 2021
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).

Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava

Pageof 1

Frequent Collaborators

3 joint publications

Davide Maria Donati

3 joint publications

Emanuela Palmerini

2 joint publications

Vanna Chiarion-Sileni

2 joint publications

Antonina Parafioriti